Antisense inhibitory effect: A comparison between 3'-partial and full phosphorothioate antisense oligonucleotides

Journal of Cellular Biochemistry

Volumn 74, Issue 1, 1999, Pages 31-37

  Galderisi, U ^a,b,c   Di Bernardo, G ^a   Melone, M A B ^a   Galano, G ^a   Cascino, A ^a   Giordano, A ^b   Cipollaro, M ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b FOX CHASE CANCER CENTER   (United States)

^c Ist di Farmacologia e Tossicologia   (Italy)

Author keywords

Antisense oligonucleotides; Chimeric oligonucleotides; N myc; Neuroblastoma

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NEUROBLASTOMA CELL; ONCOGENE C MYB; PRIORITY JOURNAL; RNA ANALYSIS;

BASE SEQUENCE; BLOOD; DNA PRIMERS; GENE EXPRESSION REGULATION; GENES, MYC; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; ORGANOPHOSPHORUS COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0033168879     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990701)74:1<31::AID-JCB4>3.0.CO;2-N     Document Type: Article

References (19)

1. Agrawal S. 1996. Antisense therapeutics. Totowa, NJ: Humana Press.
2. Capaccioli S, Di Pasquale G, Mini E, Mazzei T, Quattrone A. 1993. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem Biophys Res Comm 197(2): 818-825.
3. Chadwick DJ, Cardew G. 1997. Oligonucleotides as therapeutic agents. West Sussex, UK: John Wiley & Sons.
4. Crooke ST. 1992. Therapeutic application of oligonucleotides. Annu Rev Pharmacol Toxicol 32:29-376.
5. Dean NM, McKay R. 1994. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 91:11762-11766.
6. Foley J, Cohn SL, Salwen HR, Chagnovich D, Cowan J, Mason KL, Parysek LM. 1991. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res 51:6338-6345.
7. Galderisi U, Cipollaro M, Melone MAB, Iacomino G, Di Bernardo G, Galano G, Zappia V, Cascino A. 1996. Myotonic dystrophy: Antisense oligonucleotide inhibition of DMPK gene expression in vitro. Biochem Biophys Res Comm 221:750-754.
8. Guvakova MA, Yakubo LA, Vlodavsky I, Tonkinson JH, Stein CA. 1995. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibits its binding sites on extracellular matrix. J Biol Chem 270(6):2620-2627.
9. Helene C. 1994. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 30A:1721-1726.
10. Helene C, Saison-Behomaras E. 1994. la stratègie antisense: Nouvelles approches thèraupeutiques. Medicine/ Science 3(10):253-273.
11. Iacomino G, Galderisi U, Cipollaro M, Di Biase S, La Colla P, Marongiu ME, De Rienzo A, De Falco S, Galano G, Cascino A. 1994. Phosphorothioated antisense oligonucleotides: prospects for AIDS therapy. Life Science Advances: Mol Biol 13:69-74.
12. Ibson JM, Rabbitts PH. 1988. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Oncogene 2(4):399-402.
13. Negroni A, Scarpa S, Romeo A, Ferrari S, Modesti A, Raschellà G. 1991. Decrease of proliferation rate and induction of differentiation by MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Diff 2:511-518.
14. Romano G, Claudio PP, Kaiser HE, Giordano A. 1998. Recent advances, prospects and problems in designing new strategies for oligonucleotides and gene delivery in therapy. In Vivo 12:59-68.
15. Rosolen A, Whitesell L, Ikegaki N, Kennett RH, Neckers LM. 1990. Antisense inhibition of a single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. Cancer Res 50:6316-6322.
16. Stein CA, Cheng YC. 1993. Antisense oligonucleotides as therapeutic agents is the bullet really magical. Science 261:1004-1012.
17. Stein CA, Krieg M. 1998. Applied antisense oligonucleotide technology. Springer-Verlag: New York, NY.
18. Summerton J, Stein D, Ben Huang S, Matthew, Weller D, Partridge M. 1997. Morpholino and phosphorothioate antisense oligomers compared in cell-free and in cell system. Antisense Nucl Acid Drug Dev 7(2):63-70.
19. Yaswen P, Stampfer MR, Ghosh K, Cohen JS. 1993. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res Dev 3:67-77.